KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Adaptive Biotechnologies (ADPT) Shares Outstanding (Diluted Average): 2020-2025

Historic Shares Outstanding (Diluted Average) for Adaptive Biotechnologies (ADPT) over the last 5 years, with Sep 2025 value amounting to $163.2 million.

  • Adaptive Biotechnologies' Shares Outstanding (Diluted Average) rose 10.61% to $163.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $163.2 million, marking a year-over-year increase of 10.61%. This contributed to the annual value of $147.1 million for FY2024, which is 1.88% up from last year.
  • Adaptive Biotechnologies' Shares Outstanding (Diluted Average) amounted to $163.2 million in Q3 2025, which was up 7.29% from $152.1 million recorded in Q2 2025.
  • In the past 5 years, Adaptive Biotechnologies' Shares Outstanding (Diluted Average) registered a high of $163.2 million during Q3 2025, and its lowest value of $140.4 million during Q4 2021.
  • Its 3-year average for Shares Outstanding (Diluted Average) is $148.1 million, with a median of $147.1 million in 2024.
  • Data for Adaptive Biotechnologies' Shares Outstanding (Diluted Average) shows a peak YoY increased of 10.61% (in 2025) over the last 5 years.
  • Over the past 5 years, Adaptive Biotechnologies' Shares Outstanding (Diluted Average) (Quarterly) stood at $140.4 million in 2021, then climbed by 1.54% to $142.5 million in 2022, then climbed by 1.31% to $144.4 million in 2023, then grew by 1.88% to $147.1 million in 2024, then grew by 10.61% to $163.2 million in 2025.
  • Its last three reported values are $163.2 million in Q3 2025, $152.1 million for Q2 2025, and $149.2 million during Q1 2025.